BOETTCHER HENNIG,BARTOSZYK GERD,HARTING JUERGEN,VAN AMSTERDAM CHRISTOPH,SEYFRIED CHRISTOPH,BÖTTCHER HENNIG,HARTING JÜRGEN
申请号：
PL36174101
公开号：
PL212087B1
申请日:
2001.12.24
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
Compound of the formula (I) in which R<；SUP>；1<；/SUP>；, R<；SUP>；2 <；/SUP>；and alk are as defined in Claim 1, are potent 5-HT<；SUB>；2A <；/SUB>；antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Hutington's disease, eating disorders, such as bulimia, anorexia nervosa, premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD).
